Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by UBS Group

UBS Group upgraded shares of Option Care Health (NASDAQ:OPCHFree Report) from a neutral rating to a buy rating in a research note released on Wednesday morning, MarketBeat Ratings reports. They currently have $40.00 price objective on the stock, up from their previous price objective of $38.00.

Several other research analysts also recently weighed in on the company. JMP Securities restated a “market outperform” rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Monday, April 21st. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $35.50.

Check Out Our Latest Report on OPCH

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $32.95 on Wednesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a 1 year low of $21.39 and a 1 year high of $35.53. The firm has a fifty day moving average price of $33.35 and a 200-day moving average price of $28.85. The stock has a market cap of $5.41 billion, a PE ratio of 27.69, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Option Care Health (NASDAQ:OPCHGet Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period last year, the firm earned $0.26 earnings per share. The business’s quarterly revenue was up 16.3% on a year-over-year basis. Equities analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several institutional investors have recently modified their holdings of the stock. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC raised its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its holdings in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after acquiring an additional 332 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Analyst Recommendations for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.